Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Ovarian Neoplasms 17Uterine Cervical Neoplasms 9Endometrial Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 6Fallopian Tube Neoplasms 4Carcinoma, Ovarian Epithelial 4Uterine Neoplasms 3Pancreatic Neoplasms 3Prostatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Genital Neoplasms, Female 2Esophageal Neoplasms 2Colorectal Neoplasms 2Uterine Cervical Dysplasia 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Trophoblastic Neoplasms 1Triple Negative Breast Neoplasms 1Thymus Neoplasms 1Thymoma 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Recurrence 1Rectal Neoplasms 1Peritoneal Neoplasms 1Neuroendocrine Tumors 1Neoplasms by Site 1

Interventions

Carboplatin 19Paclitaxel 17Cisplatin 9Gemcitabine 7Cyclophosphamide 7Bevacizumab 6Topotecan 5pembrolizumab 4olaparib 4liposomal doxorubicin 4durvalumab 4Letrozole 4Interleukin-2 4Drug Therapy 4Doxorubicin 4Albumin-Bound Paclitaxel 4rucaparib 3fludarabine 3chiauranib 3cemiplimab 3camrelizumab 3Therapeutics 3Itraconazole 3Injections 3Hyperthermic Intraperitoneal Chemotherapy 3Everolimus 3pazopanib 2iniparib 2eprenetapopt 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Pemetrexed × Gynecologic × Clear all
NCT04680988 2025-08-05

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
194 enrolled
Gynecologic

Uterine Cervical Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡